MedPath

Is beta-lactam therapy, until the patient has been afebrile for 48 hours (at least 5 days), sufficient for the treatment of community-acquired pneumonia?

Completed
Conditions
Community-acquired pneumonia
Respiratory
Pneumonia
Registration Number
ISRCTN14523624
Lead Sponsor
The Research Committee of Orebro County Council (Sweden)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
200
Inclusion Criteria

Adult patients with uncomplicated febrile community-acquired pneumonia, with chest X-ray infiltrates, who initially experience improvement with beta-lactam monotherapy

Exclusion Criteria

Nursing home resident, hospitalisation during the preceding month, antibiotic treatment for any reason during the preceding week, ongoing antipyretic medication. Inability to make a telephone conversation or to attend to a follow-up visit

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Clinical cure at the four-week-visit<br>2. Recurrence of pneumonia within one month
Secondary Outcome Measures
NameTimeMethod
1. Resolution of X-ray infiltrates<br>2. C-reactive protein-level at the four-week-visit<br>3. Reported fever, cough and of physical and mental condition at the telephone conversation or at the follow-up visit
© Copyright 2025. All Rights Reserved by MedPath